Back to search results

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Abroad (travel likely)RecruitingPHASE1

Conditions

Relapsed/Refractory Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Standford Cancer Institute, Palo Alto, California, United States

    Contact: Study coordinator (Michaela Liedtke) · mliedtke@stanford.edu · 650-723-0501

  • Sylvester Cancer Center, Miami, Florida, United States

  • Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Nishi Shah, MD) · nishi.nilesh@emory.edu · 404-778-0659

  • University of Chicago Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Benjamin Derman, MD) · bendermanmd@gmail.com · 8472758131

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Shonali Midha, MD) · shonali_midha@dfci.harvard.edu · 617-632-2104

  • Montefiore Medical Center, The Bronx, New York, United States

    Contact: Study coordinator (David Levitz) · dlevitz@montefiore.org · 860-918-6192

  • University of North Carolina, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Eben Lichtman) · eben_lichtman@med.unc.edu · 6178426051

  • Tennessee Oncology, Nashville, Tennessee, United States

  • Virginia Commonwealth University (VCU), Richmond, Virginia, United States

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Binod Dhakal, MD) · bdhakal@mcw.edu · 4148054600

  • Concord Hospital, Concord, New South Wales, Australia

    Contact: Study coordinator (Nicole Wong Doo) · nicole.wongdoo@health.nsw.gov.au · +61 2 9767 7243

  • Pindara Private Hospital, Benowa, Queensland, Australia

    Contact: Study coordinator (Hanlon Sia, MBBS(Adelaide), FRACP, FRCPA) · drsia@fiho.com.au

  • St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia

    Contact: Study coordinator (Hang Quach) · hang.quach@svha.org.au · 03 9231 2003

  • Peter MacCallum Cancer Center, Melbourne, Victoria, Australia

    Contact: Study coordinator (Amit Khot) · Amit.Khot@petermac.org · +6138559500

  • Linear Clinical Research, Nedlands, Western Australia, Australia

    Contact: Study coordinator (Bradley Augustston) · bradley.augustson@health.wa.gov.au · +61 (0) 8 6382 5100

  • CHRU Lille, Lille, Hauts-de-France, France

    Contact: Study coordinator (Salomon Manier, MD) · salomon.manier@chru-lille.fr · +33-320444292

  • CHU Poiters - Hospital la Miletrie, Poitiers, New Aquitaine, France

    Contact: Study coordinator (Xavier Leleu, MD) · xavier.leleu@chu-poitiers.fr · +33-240083271

  • CHU de Nantes - Hotel Dieu, Nantes, Pays de la Loire Region, France

    Contact: Study coordinator (Cyrille Touzeau, MD) · cyrille.touzeau@chu-nantes.fr · +33-240083271

  • Groupe Hospitalier Pitie-Salpetriere, Paris, Île-de-France Region, France

    Contact: Study coordinator (Laurent Garderet, MD) · laurent.garderet@aphp.fr · +33-611010920

  • Apollo Hospital International Limited, Gandhinagar, Gujarat, India

  • Health Care Global Enterprises Ltd., Bangalore, Karnataka, India

  • Deenanath Mangeshkar Hospital and Research Centre, Pune, Maharashta, India

  • Apollo Cancer Centers, Hyderabad, Telangana, India

  • HCG Hospital, Bangalore, India

  • ASST Spedali Civili di Brescia, Brescia, Lombardy, Italy

  • Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy

    Contact: Study coordinator (Matteo Da Via) · matteo.davia@policlinico.mi.it · +39-255033421

  • Oslo University Hospital, Oslo, Oslo, Norway

    Contact: Study coordinator (Fredrik Schjesvild, MD) · fredrikschjesvold@gmail.com · +47-02770

  • Instituto de Investigacion Biomedica de Salamanca (IBSAL), Salamanca, Castile de Leon, Spain

    Contact: Study coordinator (Maria-Victoria Mateos, MD) · mvmateos@usal.es · +34-923291100

  • Institut Catala de Oncologia (ICO), Badalona, Catalonia, Spain

    Contact: Study coordinator (Laura Abril, MD) · labril@iconcologia.net · +34-934978706

  • Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain

    Contact: Study coordinator (Laura Rosinol, MD) · lrosinol@clinic.cat · +34-932275428

  • Centro Integral Oncologici Clara Campal, Madrid, Madrid, Spain

  • Clinica Universidad de Nevarra, Pamplona, Navarre, Spain

    Contact: Study coordinator (Paula Rodriguez Otero, MD) · paurodriguez@unav.es · +34-948296397
View source on ClinicalTrials.gov(opens in a new tab)